RB1CC1 Activates RB1 Pathway and Inhibits Proliferation and Cologenic Survival in Human Cancer

Tokuhiro Chano, Kaichiro Ikebuchi, Yasuko Ochi et al. · 2010

Read RB1CC1 Activates RB1 Pathway and Inhibits Proliferation and Cologenic Survival in Human Cancer by Tokuhiro Chano, Kaichiro Ikebuchi, Yasuko Ochi et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011404.txt.

Description

Tokuhiro Chano and colleagues showed in 2010 that a protein called RB1CC1 can switch a key growth brake back on in human cancer cells. The RB1 pathway normally stops cells from dividing without control, and cancers often disable it. Rather than adding a foreign drug, the team raised the level of this built-in activator.

With more RB1CC1, cancer cells grew more slowly and formed far fewer colonies, the lab sign of a tumor's power to spread from single cells. Reactivating a brake the cell already owns is an appealing strategy, since it works with normal control systems. The result names RB1CC1 as both a marker and a possible lever in cancer. Tumors that have lost it may be the ones most in need of drugs that restore the same braking effect.

Catalog record

CREATORTokuhiro Chano, Kaichiro Ikebuchi, Yasuko Ochi et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011404

Browse the full library · About the Tower of Babel